EA201892257A1 - Анти-cd3 антитела и способы применения - Google Patents

Анти-cd3 антитела и способы применения

Info

Publication number
EA201892257A1
EA201892257A1 EA201892257A EA201892257A EA201892257A1 EA 201892257 A1 EA201892257 A1 EA 201892257A1 EA 201892257 A EA201892257 A EA 201892257A EA 201892257 A EA201892257 A EA 201892257A EA 201892257 A1 EA201892257 A1 EA 201892257A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
antibodies
application
invention proposed
differentiation cluster
Prior art date
Application number
EA201892257A
Other languages
English (en)
Inventor
Сиаочэн Чэнь
Марк С. Деннис
Аллен Дж. Джр. Эбенс
Тиму Т. Джунттила
Роберт Ф. Келли
Мэри А. Мэтиеу
Липин Л. Сунь
Original Assignee
Дженентек, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дженентек, Инк. filed Critical Дженентек, Инк.
Publication of EA201892257A1 publication Critical patent/EA201892257A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

В изобретении предложены антитела к кластеру дифференцировки 3 (CD3) и способы их применения.
EA201892257A 2014-12-12 2014-12-17 Анти-cd3 антитела и способы применения EA201892257A1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462091441P 2014-12-12 2014-12-12

Publications (1)

Publication Number Publication Date
EA201892257A1 true EA201892257A1 (ru) 2019-03-29

Family

ID=65949991

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201892257A EA201892257A1 (ru) 2014-12-12 2014-12-17 Анти-cd3 антитела и способы применения

Country Status (1)

Country Link
EA (1) EA201892257A1 (ru)

Similar Documents

Publication Publication Date Title
EA201691266A1 (ru) Анти-cd3 антитела и способы применения
PH12018500711A1 (en) Anti-pd1 antibodies and methods of use
EA201790984A1 (ru) Анти-cd79b антитела и способы их применения
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
CL2017000545A1 (es) Anticuerpos anti-her2 e inmunoconjugados
MX2020009461A (es) Anticuerpos anti-proteína que contiene dominio de inmunologlubina rfig elacionado con el receptor de poliovirus (pvrig) y métodos de uso.
PH12017500982A1 (en) Heterodimeric antibodies that bind cd3 and cd38
MX2021003704A (es) Anticuerpos heterodimericos que se unen a cd3 y a antigenos tumorales.
EA201691610A8 (ru) Анти-jagged1 антитела и способы применения
MD3827845T2 (ro) Formulări subcutanate de anticorpi anti-CD38 și utilizări ale acestora
MA40682B1 (fr) Anticorps anti-ox40 et procédés d'utilisation correspondants
EP4335874A3 (en) Anti-hla-g antibodies and use thereof
MX2015012326A (es) Anticuerpos anti-crth2 y su uso.
EA201600473A1 (ru) ГУМАНИЗИРОВАННЫЕ АНТИТЕЛА К Tau(PS422) И СПОСОБЫ ПРИМЕНЕНИЯ
MX2020010951A (es) Anticuerpos anti-hla-g y utilizacion de los mismos.
EA201890747A1 (ru) Способы лечения воспалительных заболеваний
NZ730186A (en) Humanized anti-hepcidin antibodies and uses thereof
MA39355A1 (fr) Anticorps anti-ox40 et procédés d'utilisation correspondants
EA201892257A1 (ru) Анти-cd3 антитела и способы применения
CL2018002006A1 (es) Anticuerpos anti-cd3 y métodos de uso (divisional solicitud 201601556)
MY192384A (en) Anti-cd3 antibodies and methods of use
MA40663A1 (fr) Anticorps hétérodimériques se liant aux antigènes cd3 et cd38